Drug Type Small molecule drug |
Synonyms BMS 777607, BMS-777607, BMS-797669 |
Target |
Mechanism MST1R inhibitors(Macrophage-stimulating protein receptor inhibitors), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H19ClF2N4O4 |
InChIKeyVNBRGSXVFBYQNN-UHFFFAOYSA-N |
CAS Registry1025720-94-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | AU | 01 Mar 2008 | |
Breast Cancer | Phase 2 | - | - | |
Breast Cancer | Phase 2 | - | - | |
Head and Neck Neoplasms | Phase 2 | AU | - | |
Prostatic Cancer | Phase 2 | AU | - | |
Renal Cell Carcinoma | Phase 2 | AU | - | |
Stomach Cancer | Phase 2 | AU | - | |
Stomach Cancer | Phase 2 | - | - | |
Malignant Solid Neoplasm | Phase 1 | - | 01 Oct 2012 | |
Metastatic Solid Tumor | Phase 1 | - | 01 Oct 2012 |
Phase 1 | 40 | iwpwrqyyvj(jffxavhclb) = rblehbkgko tjvgniazqp (xmfhtymixh ) View more | Positive | 01 Oct 2018 |